Creating a stable tympanic membrane perforation using mitomycin C

Abstract

Objective: To determine the ability of topically applied mitomycin C to create a stable tympanic membrane perforation. Study Design and Setting: Twenty-four rats underwent subtotal removal of the tympanic membranes bilaterally. Forty ears received 0.2 mg/ml of mitomycin C. The remaining 8 received phosphate-buffered saline solution (control). Photographs taken every 3 to 5 days for 44 days were digitally scanned and computer analyzed to calculate the percentage of residual perforation. Application of solutions, photography, and data analysis were performed in a blinded fashion. Results: The mitomycin C treated ears had delayed closure time and healing rate (from day 0 to 25) compared to the control group. All controls healed by day 14. By day 44, 92.5% of the mitomycin C treated ears healed. Conclusion: Mitomycin C prolongs the closure and healing rate of myringotomies in rat tympanic membranes. Significance: Myringotomy with concurrent mitomycin C application may be useful for creating an animal model for chronic tympanic membrane perforation and should be tested in human beings as a method to maintain myringotomy patency for long-term ventilation. (Otolaryngol Head Neck Surg 2001;124:40-5)